Get the latest Science News and Discoveries

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk


A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of Risk

Risk

Photo of Stroke

Stroke

Photo of Ozempic

Ozempic

Related news:

News photo

New study aids earlier diagnosis of pancreatic cancer in patients with low-risk pancreatic cysts - EurekAlert!

News photo

Scientists discover why Alzheimer’s risk hits women so much harder

News photo

Research alert: Poor sleep tied to Alzheimer’s risk in older women - EurekAlert!